Sector revisions Macro Group Pharmaceuticals (Macro Capital) S.A.E

Stocks

End-of-day quote Egyptian Exchange 2026-09-29			5-day change	1st Jan Change
1.480 ^EGP	+1.37%		-11.90%	+29.82%

05-17	Macro Group Pharmaceutical Q1 consol profit egp 33.3 million	RE
05-16	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E	-	-	-	1
ELI LILLY AND COMPANY				29
JOHNSON & JOHNSON				22
ABBVIE INC.				28
MERCK & CO., INC.				25
ROCHE HOLDING AG				19
NOVARTIS AG				22
ASTRAZENECA PLC				23
AMGEN INC.				29
GILEAD SCIENCES, INC.				26
NOVO NORDISK A/S				23
PFIZER INC.				26
VERTEX PHARMACEUTICALS INCORPORATED				28
BRISTOL-MYERS SQUIBB COMPANY				24
MCKESSON CORPORATION				14
GSK PLC				21
SANOFI				24
MODERNA, INC.				18
REGENERON PHARMACEUTICALS, INC.				26
MERCK KGAA				14
Average				22
Weighted average by Cap.				25